FDA Approved Products
6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
EQUAGESIC
aspirin; meprobamate
LOE Approaching
PharmaIN
ORAL · TABLET
anxiety
1960
NDA30/100
EQUANIL
meprobamate
LOE Approaching
Thayer Medical
ORAL · TABLET
anxiety disordersfor the short-term relief of the symptoms of anxiety+1
1955
NDA30/100
EQUETRO
carbamazepine
LOE Approaching
Bausch Health
ORAL · CAPSULE, EXTENDED RELEASE
acute manicgeneralized tonic-clonic seizures+5
2004
NDA30/100
ERAXIS
anidulafungin
LOE Approaching
INTRAVENOUS · POWDER
the following Candida infections: intra-abdominal abscessperitonitis in adults+2
2006
NDA30/100
ERAXIS
anidulafungin
LOE Approaching
Pfizer
INJECTION · INJECTABLE
the following Candida infections: intra-abdominal abscessperitonitis in adults+2
2006
NDA30/100
ERGAMISOL
levamisole hydrochloride
LOE Approaching
Johnson & Johnson
ORAL · TABLET
1990
NDA30/100
ERTACZO
sertaconazole nitrate
LOE Approaching
Lacer
TOPICAL · CREAM
2003
NDA30/100
ERYC
erythromycin
LOE Approaching
Dr. Reddy's Laboratories
ORAL · CAPSULE, DELAYED REL PELLETS
the following infections caused by Chlamydia trachomati s: conjunctivitis of the newbornpneumonia of infancy+9
1981
NDA30/100
ERYC SPRINKLES
erythromycin
LOE Approaching
Pfizer
ORAL · CAPSULE, DELAYED REL PELLETS
the following infections caused by Chlamydia trachomatis : conjunctivitis of the newbornpneumonia of infancy+6
1985
NDA30/100
ERYCETTE
erythromycin
LOE Approaching
Johnson & Johnson
TOPICAL · SWAB
the following infections caused by Chlamydia trachomatis : conjunctivitis of the newbornpneumonia of infancy+6
1985
NDA30/100
ERYGEL
erythromycin
LOE Approaching
Viatris (2)
TOPICAL · GEL
the following infections caused by Chlamydia trachomatis : conjunctivitis of the newbornpneumonia of infancy+6
1987
NDA30/100
ERYPED
erythromycin ethylsuccinate
LOE Approaching
ORAL · GRANULE
the following infections caused by Chlamydia trachomatis : conjunctivitis of the newbornpneumonia of infancy+9
1965
NDA30/100
ERYPED
erythromycin ethylsuccinate
LOE Approaching
R-Pharm US
ORAL · TABLET, CHEWABLE
the following infections caused by Chlamydia trachomatis : conjunctivitis of the newbornpneumonia of infancy+9
1970
NDA30/100
ERYTHROCIN
erythromycin lactobionate
LOE Approaching
Pfizer
INJECTION · INJECTABLE
penicillin-allergic patientsthe treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below+1
1964
NDA30/100
ERYTHROCIN
erythromycin lactobionate
LOE Approaching
Pfizer
INJECTION · INJECTABLE
penicillin-allergic patientsthe treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below+1
1986
NDA30/100
ERYTHROMYCIN
erythromycin
LOE Approaching
Eli Lilly and Company
TOPICAL · SOLUTION
the following infections caused by Chlamydia trachomatis : conjunctivitis of the newbornpneumonia of infancy+6
1980
NDA30/100
ESCITALOPRAM
escitalopram
Launch
Almatica Pharma
ORAL · CAPSULE
anxiety
2025
NDA30/100
ESCLIM
estradiol
LOE Approaching
TRANSDERMAL · SYSTEM
moderate to severe vasomotor symptoms due to menopause ()
1998
NDA30/100
ESIDRIX
hydrochlorothiazide
LOE Approaching
Novartis
ORAL · TABLET
hypertension
1959
NDA30/100
ESKALITH
lithium carbonate
LOE Approaching
Enthera Pharmaceuticals
ORAL · CAPSULE
1970
NDA30/100
ESKALITH
lithium carbonate
LOE Approaching
ORAL · TABLET
1979
NDA30/100
ESKALITH CR
lithium carbonate
LOE Approaching
ORAL · TABLET, EXTENDED RELEASE
1982
NDA30/100
ESOMEPRAZOLE STRONTIUM
esomeprazole strontium
Peak
R-Pharm US
ORAL · CAPSULE, DELAYED RELEASE
2013
NDA30/100
ESTINYL
ethinyl estradiol
LOE Approaching
Merck & Co.
ORAL · TABLET
pregnancy
1943
NDA30/100